ADVIA CENTAUR XP INTACT PARATHYROID HORMONE (PTH) ASSAY N/A 10699154

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2019-05-22 for ADVIA CENTAUR XP INTACT PARATHYROID HORMONE (PTH) ASSAY N/A 10699154 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[146377946] The high results were reported on april 16th and april 25th. The quality control and calibrations were checked and were acceptable. All the results were from the same reagent pack. All the repeated samples were using the same tube. A field service engineer (fse) was dispatched to the customer site. Awaiting the details of the fse report to be provided. Siemens healthcare diagnostics is awaiting further information. The interpretation of results of the instructions for use states: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings". The limitations section of the instructions for use states: "interpretation of intact pth values should always take into account serum calcium results and the interrelationship between these 2 elements in various disorders involving pth and calcium. It is recommended that the intact pth results should always be interpreted with caution and with consideration of the overall clinical manifestations even when used in conjunction with calcium values.. ". Mdr 1219913-2019-00094 was filed for the same event.
Patient Sequence No: 1, Text Type: N, H10


[146377947] Discordant high advia centaur xp intact parathyroid hormone (pth) results were obtained for a "big amount" of patient samples. The results were higher than expected. The samples were repeated, and the results were lower. It is unknown if patient treatment was prescribed or altered. There was no report of adverse health consequences as a result of the discordant pth result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2019-00081
MDR Report Key8632776
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2019-05-22
Date of Report2019-06-18
Date of Event2019-04-16
Date Mfgr Received2019-05-30
Device Manufacturer Date2018-10-05
Date Added to Maude2019-05-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP INTACT PARATHYROID HORMONE (PTH) ASSAY
Generic NamePTH IMMUNOASSAY
Product CodeCEW
Date Received2019-05-22
Model NumberN/A
Catalog Number10699154
Lot Number24274021
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2019-05-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.